Adolescents consume around two-thirds of their daily calories from ultra-processed foods (UPFs), new research from the Universities of Cambridge and Bristol has found.
Researchers and clinicians are now welcoming new perspectives: those of people with experience of cancer.
Two-thirds of the public say they are very or somewhat worried about being told they have cancer – higher than for any other medical condition – according to polling released today.
‘Game changing’ technology which can predict how patients will respond to cancer treatment is part of a wave of Cambridge research harnessing AI to fight the disease.
Work will begin soon on a new hospital that will transform how we diagnose and treat cancer. Cambridge Cancer Research Hospital will treat patients across the East of England, but the research that takes place there promises to change the lives of cancer patients across the UK and beyond.
Cambridge scientists have developed an artificially-intelligent tool capable of predicting in four cases out of five whether people with early signs of dementia will remain stable or develop Alzheimer’s disease.
Artificial intelligence (AI) could be used to identify drug resistant infections, significantly reducing the time taken for a correct diagnosis, Cambridge researchers have shown. The team showed that an algorithm could be trained to identify drug-resistant bacteria correctly from microscopy images alone.
Pseudomonas aeruginosa – an environmental bacteria that can cause devastating multidrug-resistant infections, particularly in people with underlying lung conditions – evolved rapidly and then spread globally over the last 200 years, probably driven by changes in human behaviour, a new study has found.
Scientists have identified a gene which, when missing or impaired, can cause obesity, behavioural problems and, in mothers, postnatal depression. The discovery, reported on 2 July in Cell, may have wider implications for the treatment of postnatal depression, with a study in mice suggesting that oxytocin may alleviate symptoms.
Whole genome sequencing has improved clinical care of some children with cancer in England by informing individual patient care. Research published today supports the efforts to provide genome sequencing to all children with cancer and shows how it can improve the management of care in real-time, providing more benefits than all current tests combined.
© 2025 University of Cambridge